Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells

Frontiers in Cellular Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Alural, Begum ^a   Ozerdem, Aysegul ^a   Allmer, Jens ^b   Genc, Kursad ^a   Genc, Sermin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Bipolar disorder; Lithium; miR 34a; NRF2; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CERAMIDE GLUCOSYLTRANSFERASE; HEME OXYGENASE 1; LITHIUM; MESSENGER RNA; MICRORNA 34A; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NEUROPROTECTION; PARAQUAT POISONING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84930665355     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00209     Document Type: Article

References (69)

1. Agostini, M., and Knight, R. A. (2014). miR-34: from bench to bedside. Oncotarget 5, 872-881.
2. Allagui, M. S., Nciri, R., Rouhaud, M. F., Murat, J. C., El Feki, A., Croute, F., et al. (2009). Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem. Res. 34, 453-462. doi: 10.1007/s11064-008-9804-8
3. Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., and Patel, N. K. (2013). GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138, 155-175. doi: 10.1016/j.pharmthera.2013.01.004
4. Bai, X. Y., Ma, Y., Ding, R., Fu, B., Shi, S., and Chen, X. M. (2011). miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J. Am. Soc. Nephrol. 22, 1252-1261. doi: 10.1681/ASN.2010040367
5. Baltazar, M. T., Dinis-Oliveira, R. J., de Lourdes Bastos, M., Tsatsakis, A. M., Duarte, J. A., Carvalho, F., et al. (2014). Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-a mechanistic approach. Toxicol. Lett. 230, 85-103. doi: 10.1016/j.toxlet.2014.01.039
6. Bavamian, S., Mellios, N., Lalonde, J., Fass, D. M., Wang, J., Sheridan, S. D., et al. (2015). Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol. Psychiatry 20, 573-584. doi: 10.1038/mp.2014.176
7. Berry, C., La Vecchia, C., and Nicotera, P. (2010). Paraquat and Parkinson's disease. Cell Death Differ. 17, 1115-1125. doi: 10.1038/cdd.2009.217
8. Bhalala, O. G., Srikanth, M., and Kessler, J. A. (2013). The emerging roles of microRNAs in CNS injuries. Nat. Rev. Neurol. 9, 328-339. doi: 10.1038/nrneurol.2013.67
9. Blanco-Ayala, T., Andérica-Romero, A. C., and Pedraza-Chaverri, J. (2014). New insights into antioxidant strategies against paraquat toxicity. Free Radic. Res. 48, 623-640. doi: 10.3109/10715762.2014.899694
10. Blandini, F. (2013). Neural and immune mechanisms in the pathogenesis of Parkinson's disease. J. Neuroimmune. Pharmacol. 8, 189-201. doi: 10.1007/s11481-013-9435-y
11. Blesa, J., Phani, S., Jackson-Lewis, V., and Przedborski, S. (2012). Classic and new animal models of Parkinson's disease. J. Biomed. Biotechnol. 2012:845618. doi: 10.1155/2012/845618
12. Buhmann, C., Arlt, S., Kontush, A., Möller-Bertram, T., Sperber, S., Oechsner, M., et al. (2004). Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol. Dis. 15, 160-170. doi: 10.1016/j.nbd.2003.10.003
13. Chang, J. R., Mukerjee, R., Bagashev, A., Del Vale, L., Chabrashvili, T., Hawkins, B. J., et al. (2011). HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J. Biol. Chem. 286, 41125-41134. doi: 10.1074/jbc.M111.268466
14. Chen, H., Wang, N., Burmeister, M., and McInnis, M. G. (2009a). MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int. J. Neuropsychopharmacol. 12, 975-981. doi: 10.1017/S1461145709000029
15. Chen, P. C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., et al. (2009b). Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc. Natl. Acad. Sci. U.S.A. 106, 2933-2938. doi: 10.1073/pnas.0813361106
16. Chiu, C. T., Scheuing, L., Liu, G., Liao, H. M., Linares, G. R., Lin, D., et al. (2014). The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int. J. Neuropsychopharmacol. 18:pyu102. doi: 10.1093/ijnp/pyu102
17. Chiu, C. T., Wang, Z., Hunsberger, J. G., and Chuang, D. M. (2013). Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol. Rev. 65, 105-142. doi: 10.1124/pr.111.005512
18. Cousins, D. A., and Grunze, H. (2012). Interpreting magnetic resonance imaging findings in bipolar disorder. CNS Neurosci. Ther. 18, 201-207. doi: 10.1111/j.1755-5949.2011.00280.x
19. Cristóvão, A. C., Choi, D. H., Baltazar, G., Beal, M. F., and Kim, Y. S. (2009). The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid. Redox Signal. 11, 2105-2118. doi: 10.1089/ars.2009.2459
20. D'Eustachio, P. (2011). Reactome knowledgebase of human biological pathways and processes. Methods Mol. Biol. 694, 49-61. doi: 10.1007/978-1-60761-977-2_4
21. Dias, V., Junn, E., and Mouradian, M. M. (2013). The role of oxidative stress in Parkinson's disease. J. Parkinsons Dis. 3, 461-491. doi: 10.3233/JPD-130230
22. Diniz, B. S., Machado-Vieira, R., and Forlenza, O. V. (2013). Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr. Dis. Treat. 9, 493-500. doi: 10.2147/NDT.S33086
23. Flicek, P., Ahmed, I., Amode, M. R., Barrell, D., Beal, K., Brent, S., et al. (2013). Ensembl 2013. Nucleic Acids Res. 41, D48-D55. doi: 10.1093/nar/gks1236
24. Forlenza, O. V., De-Paula, V. J., and Diniz, B. S. (2014). Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem. Neurosci. 5, 443-450. doi: 10.1021/cn5000309
25. Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A., and Yamawaki, S. (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology Berl. 158, 100-106. doi: 10.1007/s002130100871
26. Gan, L., and Johnson, J. A. (2014). Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim. Biophys. Acta 1842, 1208-1218. doi: 10.1016/j.bbadis.2013.12.011
27. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., et al. (2014). Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 112, 24-49. doi: 10.1016/j.pneurobio.2013.10.004
28. Goldman, S. M. (2014). Environmental toxins and Parkinson's disease. Annu. Rev. Pharmacol. Toxicol. 54, 141-164. doi: 10.1146/annurev-pharmtox-011613-135937
29. Guo, C., Sun, L., Chen, X., and Zhang, D. (2013). Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 8, 2003-2014. doi: 10.1016/j.pneurobio.2013.10.004
30. Hashimoto, R., Takei, N., Shimazu, K., Christ, L., Lu, B., and Chuang, D. M. (2002). Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 43, 1173-1179. doi: 10.1016/S0028-3908(02)00217-4
31. Hsu, S. D., Lin, F. M., Wu, W. Y., Liang, C., Huang, W. C., Chan, W. L., et al. (2011). miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, D163-D169. doi: 10.1093/nar/gkq1107
32. Hunsberger, J. G., Fesler, E. B., Chibane, F. L., Leng, Y., Maric, D., Elkahloun, A. G., et al. (2013). Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am. J. Trans. Res. 5, 450-464.
33. Jenner, P., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben-Shlomo, Y., et al. (2013). Parkinson's disease-the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J. Parkinsons Dis. 3, 1-11. doi: 10.3233/JPD-130175
34. Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., and Salminen, A. (2013). Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 25, 1939-1948. doi: 10.1016/j.cellsig.2013.06.007
35. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., and Segal, E. (2007). The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278-1284. doi: 10.1038/ng2135
36. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. doi: 10.1016/0092-8674(93)90529-Y
37. Litteljohn, D., Nelson, E., Bethune, C., and Hayley, S. (2011). The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice. Neurosci. Lett. 502, 186-191. doi: 10.1016/j.neulet.2011.07.041
38. Lowthert, L., Leffert, J., Lin, A., Umlauf, S., Maloney, K., Muralidharan, A., et al. (2012). Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol. Mood Anxiety Disord. 2:15. doi: 10.1186/2045-5380-2-15
39. Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., and Berk, M. (2013). Potential mechanisms of action of lithium in bipolar disorder. Current Understanding. CNS Drugs 27, 135-153. doi: 10.1007/s40263-013-0039-0
40. Martins, J. B., Bastos Mde, L., Carvalho, F., and Capela, J. P. (2013). Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells. J. Toxicol. 2013:347312. doi: 10.1155/2013/347312
41. Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early down regulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. doi: 10.1093/hmg/ddr210
42. Miranda, K. C., Huynh, T., Tay, Y., Ang, Y. S., Tam, W. L., Thomson, A. M., et al. (2006). A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217. doi: 10.1016/j.cell.2006.07.031
43. Milani, P., Ambrosi, G., Gammoh, O., Blandini, F., and Cereda, C. (2013). SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxid Med. Cell Longev. 2013:836760. doi: 10.1155/2013/836760
44. Moretto, A., and Colosio, C. (2013). The role of pesticide exposure in the genesis of Parkinson's disease: epidemiological studies and experimental data. Toxicology 307, 24-34. doi: 10.1016/j.tox.2012.11.021
45. Nair, A., and Vaidya, V. A. (2006). Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J. Biosci. 31, 423-434. doi: 10.1007/BF02704114
46. Narasimhan, M., Riar, A. K., Rathinam, M. L., Vedpathak, D., Henderson, G., and Mahimainathan, L. (2014). Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity. Toxicol. Lett. 228, 179-191. doi: 10.1016/j.toxlet.2014.05.020
47. Nelson, T. J., and Alkon, D. L. (2014). Molecular regulation of Synaptogenesis during associative learning and memory. Brain Res. doi: 10.1016/j.brainres.2014.11.054. [Epub ahead of print].
48. Niture, S. K., Khatri, R., and Jaiswal, A. K. (2014). Regulation of Nrf2-an update. Free Radic Biol. Med. 66, 36-44. doi: 10.1016/j.freeradbiomed.2013.02.008
49. Park, S. W., Lee, J. G., Seo, M. K., Cho, H. Y., Lee, C. H., and Lee, J. H. (2014). Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Bipolar Disord. 17, 278-290. doi: 10.1111/bdi.12262
50. Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., and Fornai, F. (2010). Intracellular pathways underlying the effects of lithium. Behav. Pharmacol. 21, 473-492. doi: 10.1097/FBP.0b013e32833da5da
51. Ruby, J. G., Stark, A., Johnston, W. K., Kellis, M., Bartel, D. P., and Lai, E. C. (2007). Evolution, biogenesis, expression, and target predictions of a substantially expanded set of Drosophila microRNAs. Genome Res. 17, 1850-1864. doi: 10.1101/gr.6597907
52. Serafin, A., Foco, L., Zanigni, S., Blankenburg, H., Picard, A., Zanon, A., et al. (2015). Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. Neurology 84, 645-653. doi: 10.1212/WNL.0000000000001258
53. Silva-Adaya, D., Gonsebatt, M. E., and Guevara, J. (2014). Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence. Oxid Med. Cell Longev. 2014:590808. doi: 10.1155/2014/590808
54. Smith-Vikos, T., and Slack, F. J. (2012). MicroRNAs and their roles in aging. J. Cell Sci. 125(Pt 1), 7-17. doi: 10.1242/jcs.099200
55. Song, N., Boku, S., Nakagawa, S., Kato, A., Toda, H., Takamura, N., et al. (2012). Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 38, 183-189. doi: 10.1016/j.pnpbp.2012.03.006
56. Stefanson, A. L., and Bakovic, M. (2014). Dietary regulation of Keap1/Nrf2/ARE pathway: focus on plant-derived compounds and trace minerals. Nutrients 6, 3777-3801. doi: 10.3390/nu6093777
57. Stroynowska-Czerwinska, A., Fiszer, A., and Krzyzosiak, W. J. (2014). The panorama of miRNA-mediated mechanisms in mammalian cells. Cell Mol. Life Sci. 71, 2253-2270. doi: 10.1007/s00018-013-1551-6
58. Subramaniam, S. R., and Chesselet, M. F. (2013). Mitochondrial dysfunction and oxidative stres in Parkinson's disease. Prog. Neurobiol. 106-107, 17-32. doi: 10.1016/j.pneurobio.2013.04.004
59. Sun, E., and Shi, Y. (2014). MicroRNAs: small molecules with big roles in neurodevelopment and diseases. Exp. Neurol. 268, 46-53. doi: 10.1016/j.expneurol.2014.08.005
60. Thomson, D. W., Bracke, C. P., and Goodall, G. J. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853. doi: 10.1093/nar/gkr330
61. Tufekci, K. U., Genc, S., and Genc, K. (2011). The endotoxin-induced neuroinflammation model of Parkinson's disease. Parkinsons Dis. 2011:487450. doi: 10.4061/2011/487450
62. Tüfekci, K. U., Meuwissen, R. L., and Genç S. (2014). The role of microRNAs in biological processes. Methods Mol. Biol. 1107, 15-31. doi: 10.1007/978-1-62703-748-8_2
63. Vallelunga, A., Ragusa, M., DiMauro, S., Iannitti, T., Pilleri, M., Biundo, R., et al. (2014). Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple systematrophy. Front. Cell Neurosci. 8:156. doi: 10.3389/fncel.2014.00156
64. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., et al. (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80, 268-273. doi: 10.1016/j.brainresbull.2009.08.006
65. Yang, W., and Tiffany-Castiglioni, E. (2008). Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria. J. Toxicol. Environ. Health A 71, 289-299. doi: 10.1080/15287390701738467
66. Yang, W., Tiffany-Castiglioni, E., Lee, M. Y., and Son, I. H. (2010). Paraquat induces cyclooxygenase-2, COX-2 implicated toxicity in human neuroblastoma SH-SY5Y cells. Toxicol. Lett. 199, 239-246. doi: 10.1016/j.toxlet.2010.09.005
67. Yang, W., Yan, Z., Hongjing, Z., Dexiang, L., Zengxun, L., Xiaojing, C., et al. (2014). The toxic effect of lithium ion on neurons, PC12 cells and Aâ42 molecules. Biol. Trace Elem. Res. 159, 410-415. doi: 10.1007/s12011-014-9949-z
68. Zhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., et al. (2009). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34, 1395-1405. doi: 10.1038/npp.2008.131
69. Zuo, L., and Motherwell, M. S. (2013). The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Gene 532, 18-23. doi: 10.1016/j.gene.2013.07.085